S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Critical asset just had biggest fall on record (Ad)
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants

Mineralys Therapeutics (MLYS) News Today

$15.34
-0.04 (-0.26%)
(As of 03/1/2024 08:52 PM ET)
SourceHeadline
marketbeat.com logoBraidwell LP Purchases 1,473,600 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS)
marketbeat.com - March 1 at 10:18 AM
seekingalpha.com logoMineralys: 2nd Half 2024 Hypertension Data Readout
seekingalpha.com - February 9 at 3:08 PM
bizjournals.com logoMineralys Therapeutics set to raise $120M from investors to develop treatment for high blood pressure
bizjournals.com - February 9 at 3:08 PM
msn.com logoMineralys Therapeutics Equity Sales: Investor Impact Report
msn.com - February 9 at 10:08 AM
msn.com logoMineralys Therapeutics Announces Strategic Purchase Agreement
msn.com - February 9 at 10:08 AM
msn.com logoMineralys Therapeutics stock jumps on $120M private placement financing
msn.com - February 8 at 2:12 PM
finance.yahoo.com logoMineralys Therapeutics Announces $120 Million Private Placement Financing
finance.yahoo.com - February 8 at 9:11 AM
marketbeat.com logoMineralys Therapeutics (NASDAQ:MLYS) Shares Gap Up to $12.70
marketbeat.com - February 2 at 11:46 AM
marketbeat.com logoMineralys Therapeutics, Inc. (NASDAQ:MLYS) Sees Large Decrease in Short Interest
marketbeat.com - January 30 at 11:18 AM
finance.yahoo.com logoMineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference
finance.yahoo.com - January 29 at 8:00 PM
finance.yahoo.com logoMineralys Therapeutics, Inc. (MLYS) Upgraded to Strong Buy: Here's What You Should Know
finance.yahoo.com - January 17 at 6:03 PM
seekingalpha.com logoMLYS Mineralys Therapeutics, Inc.
seekingalpha.com - January 6 at 11:20 PM
finance.yahoo.com logoMineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer
finance.yahoo.com - January 4 at 4:49 PM
marketbeat.com logoMineralys Therapeutics, Inc. (NASDAQ:MLYS) Short Interest Down 47.9% in December
marketbeat.com - December 29 at 9:41 PM
morningstar.com logoMineralys Therapeutics Inc MLYS
morningstar.com - December 22 at 11:23 PM
msn.com logoMineralys stock jumps 13% after first patient dosed in hypertension study
msn.com - December 22 at 1:22 PM
bizjournals.com logo2023 in Review: Region's first life sciences IPO since 2021 tops industry's biggest raises of the year
bizjournals.com - December 22 at 12:39 AM
finance.yahoo.com logoMineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
finance.yahoo.com - December 21 at 7:38 PM
finance.yahoo.com logoPositive Signs As Multiple Insiders Buy Mineralys Therapeutics Stock
finance.yahoo.com - November 27 at 12:45 PM
uk.finance.yahoo.com logoMineralys Therapeutics, Inc. (MLYS)
uk.finance.yahoo.com - November 25 at 7:32 AM
finance.yahoo.com logoMineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 12 at 10:29 AM
finance.yahoo.com logoMineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023
finance.yahoo.com - November 11 at 12:58 PM
finance.yahoo.com logoMineralys Therapeutics to Participate in Three Upcoming Conferences
finance.yahoo.com - November 9 at 6:21 PM
finance.yahoo.com logoMineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 9:01 PM
finance.yahoo.com logoMineralys Therapeutics Inc (MLYS) Reports Q3 2023 Financials; R&D Expenses Rise Amid ...
finance.yahoo.com - November 7 at 9:01 PM
finance.yahoo.com logoMineralys Therapeutics Presents New Post-Hoc Analysis from Target-HTN Phase 2 Trial of Lorundrostat in Late-Breaking Poster Session at ASN Kidney Week 2023 Meeting
finance.yahoo.com - November 2 at 1:41 PM
finance.yahoo.com logoMineralys Therapeutics to Announce Third Quarter 2023 Financial Results and Host Conference Call on Tuesday, November 7, 2023
finance.yahoo.com - October 31 at 6:43 PM
finance.yahoo.com logoWe're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate
finance.yahoo.com - October 17 at 10:13 AM
finance.yahoo.com logoMineralys Therapeutics Announces Upcoming Poster Presentations at Two Scientific Conferences in November 2023
finance.yahoo.com - October 13 at 5:26 PM
finance.yahoo.com logoPraxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy
finance.yahoo.com - September 19 at 6:13 PM
finance.yahoo.com logoMineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daphne Karydas
finance.yahoo.com - September 14 at 7:12 PM
marketbeat.com logo1,794,600 Shares in Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Bought by SR One Capital Management LP
marketbeat.com - September 13 at 8:19 AM
finance.yahoo.com logoMineralys Therapeutics to Participate in the Cantor Fitzgerald Global Healthcare Conference on Thursday, September 28, 2023
finance.yahoo.com - September 11 at 9:07 PM
finance.yahoo.com logoMineralys Therapeutics Announces JAMA Publication of Full Target-HTN Phase 2 Trial Results for Lorundrostat in Uncontrolled and Treatment-Resistant Hypertension
finance.yahoo.com - September 11 at 12:36 AM
finance.yahoo.com logoMineralys Therapeutics Presents Target-HTN Phase 2 Trial Results in Late-Breaking Science Session at 2023 AHA Hypertension Scientific Sessions
finance.yahoo.com - September 10 at 2:36 PM
finance.yahoo.com logoCEO Jon Congleton Buys 2,250 Shares of Mineralys Therapeutics Inc (MLYS)
finance.yahoo.com - September 9 at 7:32 PM
marketbeat.com logoJon Congleton Buys 2,250 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Stock
marketbeat.com - September 8 at 11:35 AM
marketbeat.com logoAmerican Century Companies Inc. Acquires New Position in Mineralys Therapeutics, Inc. (NASDAQ:MLYS)
marketbeat.com - September 6 at 4:51 AM
finance.yahoo.com logoWall Street Analysts See a 199.3% Upside in Mineralys Therapeutics, Inc. (MLYS): Can the Stock Really Move This High?
finance.yahoo.com - September 5 at 4:25 PM
finance.yahoo.com logoMineralys Therapeutics Selected for Oral Poster Presentation of Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions
finance.yahoo.com - September 5 at 4:25 PM
marketbeat.com logoExodusPoint Capital Management LP Purchases Shares of 181,312 Mineralys Therapeutics, Inc. (NASDAQ:MLYS)
marketbeat.com - August 31 at 6:00 AM
finance.yahoo.com logoMineralys Therapeutics to Participate in the Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023
finance.yahoo.com - August 29 at 6:29 PM
finance.yahoo.com logoMineralys Therapeutics, Inc. (MLYS) Loses -19.64% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
finance.yahoo.com - August 22 at 9:12 PM
marketbeat.com logoMineralys Therapeutics, Inc. (NASDAQ:MLYS) CEO Jon Congleton Purchases 2,000 Shares
marketbeat.com - August 11 at 10:30 PM
msn.com logoCredit Suisse Maintains Mineralys Therapeutics (MLYS) Outperform Recommendation
msn.com - August 8 at 1:39 PM
finance.yahoo.com logoMineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 8:38 AM
marketbeat.com logoMineralys Therapeutics, Inc.'s Lock-Up Period Set To End on August 9th (NASDAQ:MLYS)
marketbeat.com - August 2 at 1:22 AM
finance.yahoo.com logoMineralys Therapeutics to Announce Second Quarter 2023 Financial Results and Host Conference Call on Monday, August 7, 2023
finance.yahoo.com - July 31 at 8:10 PM
barrons.com logoMineralys Therapeutics Inc.
barrons.com - July 28 at 12:54 PM
seekingalpha.com logoMineralys Therapeutics: Expanded Phase 2 Trials For Chronic Kidney Disease
seekingalpha.com - July 27 at 9:41 PM
Get Mineralys Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLYS and its competitors with MarketBeat's FREE daily newsletter.



MLYS Media Mentions By Week

MLYS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MLYS
News Sentiment

1.78

0.65

Average
Medical
News Sentiment

MLYS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MLYS Articles
This Week

2

1

MLYS Articles
Average Week

Get Mineralys Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLYS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MLYS) was last updated on 3/4/2024 by MarketBeat.com Staff